Agilent Technologies, Inc. (A) vs Moderna, Inc. (MRNA)
A side-by-side comparison of Agilent Technologies, Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.
A
Agilent Technologies, Inc.
$159.00HealthcareAt close: Aug 21, 2026, 4:00 PM ET
MRNA
Moderna, Inc.
$145.13HealthcareAt close: Aug 21, 2026, 4:00 PM ET
Total return — A vs MRNA
growth of $100 · dividends reinvested · last 8yA +135.2% (+11.3%/yr)MRNA +680.3% (+29.3%/yr)MRNA compounded faster over this window
A MRNA
A vs MRNA: by the numbers
- •MRNA is the larger company ($57.59B vs $44.89B market cap).
- •A is profitable (19.55% net margin) while MRNA runs a net loss (-141.43%).
- •MRNA grew revenue faster over the past five years (19.33% vs 4.45% CAGR).
- •A pays a dividend (0.64% yield), while MRNA has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | A | MRNA |
|---|---|---|
| P/E ratio | 31.93 | N/A |
| Forward P/E | 26.24 | N/A |
| P/S ratio | 6.24 | 25.80 |
| P/B ratio | 6.34 | 8.50 |
| EV / EBITDA | 25.49 | N/A |
| FCF yield | 2.78% | N/A |
Profitability
| Metric | A | MRNA |
|---|---|---|
| Gross margin | 53.00% | 55.35% |
| Operating margin | 21.50% | -158.13% |
| Net margin | 19.55% | -141.43% |
| ROE | 19.85% | -46.61% |
| ROIC | 12.54% | -39.16% |
Dividends
| Metric | A | MRNA |
|---|---|---|
| Dividend yield | 0.64% | N/A |
| Payout ratio | 22.07% | N/A |
Growth (annualized)
| Metric | A | MRNA |
|---|---|---|
| Revenue CAGR (5Y) | 4.45% | 19.33% |
| EPS CAGR (5Y) | 14.52% | N/A |
| FCF CAGR (5Y) | 0.05% | N/A |
| Total return CAGR (5Y) | -0.41% | -17.63% |
Frequently asked
- Which has grown faster, A or MRNA?
- Over the past five years, MRNA grew revenue faster — A at a 4.45% CAGR versus MRNA at 19.33%.
- Does A or MRNA pay a bigger dividend?
- A pays a dividend (0.64% yield), while MRNA has no payments in the available dividend history.
- Is A or MRNA more profitable?
- A runs the higher net margin — A at 19.55% versus MRNA at -141.43%.
- How have A and MRNA total returns compared?
- Over the past 5 years, A delivered 13.69% and MRNA delivered -17.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agilent Technologies P/E ratioAgilent Technologies dividend yieldAgilent Technologies ROEModerna ROEAgilent Technologies operating marginModerna operating marginAgilent Technologies revenue growthModerna revenue growthAgilent Technologies free cash flowModerna free cash flow
Agilent Technologies & Moderna appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.